The authorised ANDA, Nystatin and Triamcinolone Acetonide Ointment is used to treat cutaneous candidiasis; studies have indicated that the nystatin-steroid combination is more effective in the first few days of therapy than the nystatin component alone. Alembic Pharmaceuticals Limited confirmed that its joint venture Aleor Dermaceuticals Limited has gained the final FDA clearance for its Abbreviated New Drug Application (ANDA) for Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/gram. The authorised ANDA, Nystatin and Triamcinolone Acetonide Ointment is used to treat cutaneous candidiasis; studies have indicated that the nystatin-steroid combination is more effective in the first few days of therapy than the nystatin component alone.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!